Skip to content

Alexander B Belser

Consultants, New York, NY, USA.

2 papers in the library · 47 citations · publishing 2023-2025

Papers

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.

Psychedelic medicine (New Rochelle, N.Y.) December 1, 2023 William Brennan, Alex R Kelman, Alexander B Belser 43 citations

Psychedelic-assisted therapy has attracted considerable interest, but poor reporting of psychosocial interventions (PIs) in clinical trials obscures their role in treatment outcomes. This systematic review of 33 published psychedelic clinical trials since 2000 found that many reports omitted basic details: 33% did not report the number of sessions, 45% did not report session duration, 42% did not report provider credentials, 52% did not report use of a therapy manual, 64% did not reference an available manual, and 82% did not report assessing treatment fidelity. Compared with non-psychedelic trials, psychedelic trial reports underreport key PI items. The review indicates that underreporting is a widespread problem and recommends improved reporting practices to enhance research standardization and treatment outcomes.

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Journal of psychopharmacology (Oxford, England) June 10, 2025 Torsten Passie, Anja Loizaga-Velder, Alicia Danforth et al. 4 citations

A consensus-based model curriculum for education and training in substance-assisted psychotherapy (SAP) covers theoretical topics and practical components including apprenticeship observation, ongoing clinical supervision, and self-experience for trainees. The model, developed by authors with extensive SAP experience, also addresses peer and conventional supervision, respect for intercultural differences, and teachings about indigenous use of related substances. It is largely adapted to western industrialized countries with established graduate-level psychotherapy training. The curriculum may be valuable for psychedelic researchers, those training therapists for research studies, and those preparing for clinical work outside research settings.